2022 NDARC Annual Research Symposium

Registration is now open for the 2022 NDARC Annual Research Symposium. The Symposium will showcase the work of leading national and international researchers in the alcohol and other drugs sector and related fields.

Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria

Agwogie, Martin O., 'Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria', Paper Presentation, State House Conference Centre, Abuja, Nigeria, June 2022
Publication Date

Paper presented at the commemoration of the 2022 International Day Against Drug Abuse & Illicit Trafficking, State House Conference Centre, Abuja, Nigeria on June 27th, 2022.

Author: Dr. Martin O. Agwogie

Kenya to include smoking cessation drugs as essential medicines

The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction. The World Health Organization said the two drugs bring “a powerful shift in the fight against the tobacco epidemic.” The two are bupropion and varenicline, which are more effective than the current cessation drugs, which contain nicotine.

Alcohol & Human Rights

Created by
Institute of Alcohol Studies Institute of Alcohol Studies
Publication Date

The Institute of Alcohol Studies presents Seminar Four in its four-part series on alcohol and sustainability. Seminar Four explored workers’ rights for alcohol industry employees in the developing world; industry practices in Africa, including female promotional workers’ rights and their risk of sexual harassment and assault; gender and health inequality; and how human rights litigation can be used as a last resort control policy

Alcohol Policy 19 Evidence to Action: Building a Framework for Change


The nation’s capital for the Alcohol Policy 19 Conference, convened by the U.S. Alcohol Policy Alliance will take place on September 14-16, 2022 Arlington, VA.

The 19th in a series of conferences on preventing and reducing alcohol-related problems using public policy strategies.

Risks, harms and clinical implications of Novel Psychoactive Substances


As part for the new webinar series of International Society for the Study of Emerging Drugs (ISSED), we are pleased to invite you to attend a workshop on “Health Risks, Harms and Clinical Implications of Novel Psychoactive Substances” facilitated by Prof. Giuseppe Bersani and Prof. Owen Bowden-Jones.

New psychoactive substances: A review and updates

Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020). New psychoactive substances: a review and updates. Therapeutic advances in psychopharmacology, 10, 2045125320967197.
Publication Date

New psychoactive substances (NPS) are a diverse group of substances that are linked with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care, emergency departments, psychiatric inpatient and community care settings.